» Articles » PMID: 38736758

Pleural Epithelioid Hemangioendothelioma: An Ultrarare Cause for Recurrent Pleural Effusion Managed With Trametinib and Pazopanib

Overview
Journal Cureus
Date 2024 May 13
PMID 38736758
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelioid hemangioendothelioma (EHE) is an extremely rare sarcoma of vascular origin. Primary pleural involvement is extremely under-reported and tends to have a more aggressive course. We report a case of pleural EHE in a Caucasian female in her 50s with a two-month history of dyspnea and chest pain. Investigations, including video-assisted thoracoscopy, revealed extensive pleural scarring and inflammation. Management with trametinib and pazopanib led to a stable disease course, reduction in the frequency of pleural effusion recurrence, and improvement in cancer-related pain.

Citing Articles

Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review.

Pateras I, Kostopanagiotou K, Samaras M, Koumarianou A, Koutrouli M, Korodimos N Front Pharmacol. 2024; 15:1482154.

PMID: 39650162 PMC: 11621942. DOI: 10.3389/fphar.2024.1482154.

References
1.
Kasper B, Hohenberger P . Pazopanib: a promising new agent in the treatment of soft tissue sarcomas. Future Oncol. 2011; 7(12):1373-83. DOI: 10.2217/fon.11.116. View

2.
Stacchiotti S, Miah A, Frezza A, Messiou C, Morosi C, Caraceni A . Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO Open. 2021; 6(3):100170. PMC: 8182432. DOI: 10.1016/j.esmoop.2021.100170. View

3.
Kitaichi M, NAGAI S, Nishimura K, Itoh H, Asamoto H, Izumi T . Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur Respir J. 1998; 12(1):89-96. DOI: 10.1183/09031936.98.12010089. View

4.
Lahori M, Dehghani A, Wilson C, Law W, Agaram N, Murali R . Cytopathologic features of epithelioid hemangioendothelioma including touch imprints for rapid on-site evaluation. Cytojournal. 2023; 20:29. PMC: 10559487. DOI: 10.25259/Cytojournal_57_2022. View

5.
Kollar A, Jones R, Stacchiotti S, Gelderblom H, Guida M, Grignani G . Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. Acta Oncol. 2016; 56(1):88-92. DOI: 10.1080/0284186X.2016.1234068. View